Stock CTV INNOVID CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Innovid Corp.

Equities

CTV

US4576791085

End-of-day quote Nyse
Other stock markets
 06:00:00 2024-07-02 pm EDT 		5-day change 1st Jan Change
1.73 USD +1.76% Intraday chart for Innovid Corp. -3.35% +15.33%
Jul. 01 Innovid Corp.(NYSE:CTV) added to Russell Small Cap Comp Value Index CI
Jul. 01 Innovid Corp.(NYSE:CTV) added to Russell Small Cap Completeness Index CI

Evolution of the average Target Price on Innovid Corp.

Price target over the last 5 years

History of analyst recommendation changes

df7d7bbace6b5672.T-ueiBLvewCYv-XsW-hLYqfI1NCieQvdFDxvmrPCabE.Dona71CZGUb5zb2lNKEqPcCQlunEOHGEYnAF7d2DDPcWm--wJ98hWOmNvA~adb193d9d1e70e8a04add548ce57deb7

Analyst Recommendations on Innovid Corp.

Needham Adjusts Price Target on Innovid to $3 From $2.25, Maintains Buy Rating MT
Needham Adjusts Price Target on Innovid to $2.25 From $1.50, Maintains Buy Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $1.50 From $1.40, Maintains Equalweight Rating MT
Needham Cuts Price Target on Innovid to $1.50 From $3, Keeps Buy Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $1.40 From $1.10, Keeps Equalweight Rating MT
Morgan Stanley Adjusts Price Target on Innovid to $1.10 From $2.20, Maintains Equal-Weight Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $2.20 From $2.40, Maintains Equal Wright Rating MT
JMP Securities Adjusts Price Target on Innovid to $5 From $6, Maintains Market Outperform Rating MT
Needham Adjusts Price Target on Innovid to $3 From $4, Maintains Buy Rating MT
Morgan Stanley Initiates Innovid at Underweight with $2.70 Price Target MT
Morgan Stanley Starts Innovid at Underweight with $2.70 Price Target MT
JMP Securities Trims Innovid's Price Target to $6 From $9, Keeps Market Outperform Rating MT
Needham Adjusts Innovid's Price Target to $6 from $10, Maintains Buy Rating MT
BMO Capital Adjusts Innovid's Price Target to $8 from $13, Maintains Outperform Rating MT
JMP Securities Starts Innovid at Market Outperform With $11 Price Target MT
Needham Starts Innovid at Buy With $10 Price Target MT
BMO Capital Starts Innovid at Outperform With $13 Price Target MT
Evercore ISI Starts Innovid at Outperform With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.73 USD
Average target price
2.733 USD
Spread / Average Target
+58.00%
High Price Target
3 USD
Spread / Highest target
+73.41%
Low Price Target
2.2 USD
Spread / Lowest Target
+27.17%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Innovid Corp.

Needham & Co.
Morgan Stanley
JMP Securities
BMO Capital
Evercore ISI

Ratings for Innovid Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CTV Stock
  4. Consensus Innovid Corp.